As the first precision pilot in Autism, COUNT aims to
advance the understanding of Autism Spectrum Disorder
(ASD) via a novel, tech-enabled longitudinal approach, with the
ultimate goal of managing and treating the disorder at the individual level.
This study will serve as a blueprint for studies of many chronic diseases with similarly complex etiologies, symptoms, and co-existing conditions.
2m Foundation, is a nonprofit organization based in Silicon Valley, driven by the vision to redesign a frictionless and accessible healthcare model. The foundation partners with world-renowned experts in microbiome, immunology and neuroscience to develop technology-enabled initiatives that change the way we define and manage chronic diseases.
Become a lab insider.
Sign up for our newsletter and be the first
to hear about new studies in development.